Literature DB >> 841651

The natural history of ocular onchocerciasis over a period of 14--15 years and the effect on this of a single course of suramin therapy.

F H Budden.   

Abstract

In 1959 a population of 638 persons over the age of seven years, suffering from heavy endemic onchocerciasis in the Sudan-Savannah of West Africa was examined, and approximately half were allotted to a group for treatment with suramin (up to a total of 4-2 g for healthy adults). In 1973 and 1974 it was possible to re-examine 145 persons allotted to the treatment group and 118 persons allotted to the control group. Measurements were made of the incidence of new "eye lesions", the progress of pre-existing "eye-lesions" and the deterioration in visual acuity. These were greater in men than in women, and increased with age. They were also greater in persons who in 1959 had microfilariae in the anterior chamber, and particularly in those who had already developed "eye lesions". Severe reactions occurred in a significant proportion of patients who received suramin, and one died. However, these was less deterioration in the eyes of persons in the treated than in the control group.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 841651     DOI: 10.1016/0035-9203(76)90134-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

1.  The risk of optic atrophy following suramin treatment of ocular onchocerciasis.

Authors:  B Thylefors; A Rolland
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  The microfilarial load in the anterior segment of the eye. A parameter of intensity of onchocerciasis.

Authors:  B Thylefors; U K Brinkmann
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

3.  Ocular onchocerciasis.

Authors:  B Thylefors
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

4.  [Treatment of onchocerciasis with low, increasing doses of suramin in hyperendemic communities of Western Africa: 2. Clinical parasitologic and ophthalmologic results in a zone where transmission is controlled].

Authors:  A Rougemont; M Hien; B Thylefors; A Prost; A Rolland
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

5.  [Treatment of onchocerciasis in hyperendemic communities in West Africa with small, gradually increasing doses of suramin. 1. Parasitological results and ophthalmological surveillance in a region where transmission has not been interrupted].

Authors:  A Rougemont; B Thylefors; M Ducam; A Prost; P Ranque; J Delmont
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

6.  Insights Into Onchocerca volvulus Population Biology Through Multilocus Immunophenotyping.

Authors:  Carmelle T Norice-Tra; José Ribeiro; Sasisekhar Bennuru; Michael P Fay; Rahul Tyagi; Makedonka Mitreva; Thomas B Nutman
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

7.  Onchocerciasis in Ecuador: evolution of chorioretinopathy after amocarzine treatment.

Authors:  P J Cooper; R Proaño; C Beltran; M Anselmi; R H Guderian
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

8.  A three-year follow-up of ocular onchocerciasis in an area of vector control.

Authors:  B Thylefors; A M Tønjum
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

Review 9.  Onchocerciasis drug development: from preclinical models to humans.

Authors:  Adela Ngwewondo; Ivan Scandale; Sabine Specht
Journal:  Parasitol Res       Date:  2021-10-13       Impact factor: 2.289

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.